MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Portfolio Companies: Cardinal
Axogen, Inc. (NASDAQ: AXGN)*
Organization & Developments: AxoGen
Parents
Axogen, Inc. (NASDAQ: AXGN)*
Children
*First distributed peripheral nerve repair option which preserves the nerve extracellular matrix from donated allograft tissue.
*Provide surgeons with solutions to repair and protect peripheral nerves.
*Revenue stage company providing a family of unique and proprietary products to reconstruct peripheral nerves
*This knowledge was combined with research from Dr. David Muir, PhD, from the University of Florida McKnight Brain Institute and Dr. Christine Schmidt, PhD, from the University of Texas Austin.
2016: Building a biotech without millions in the bank
2018: Is AxoGen A Buy On The Dip?_seekingalpha.com
2019: Axogen to increase enrollment in late-stage nerve graft study; shares down 4% premarket _ seekingalpha.com
2020: AxoGen: Operating Efficiencies Come Through The P&L And Cash-Flow Statements
2022: Axogen Needs RECON More Than Ever To Recharge The Bull Case_seekingalpha.com
2022: AxoGen: Rally Looks To Be Exhausted, Revise To Hold_seekingalpha.com
2023: AxoGen: Continued Sales Growth, 3x Added Capacity, Strong Outlook (Rating Upgrade)
2024: AxoGen: An Intriguing Growth Story_ seekingalpha.com
Jumps
*Key People: AxoGen
Finance & Acquisition: AxoGen